Bladder Cancer
February 2018 Issue
 
 
 

Nearly every major medical breakthrough over the past 50 years can be attributed to new discoveries that were made possible through meticulous biomedical research. Many diseases and conditions that previously took a heavy toll on patients in terms of both morbidity and mortality are now either treatable or preventable thanks in large part to painstaking research that expanded the frontiers of scientific knowledge and moved the most promising basic research developments into tangible health benefits through human clinical trails. Ongoing research is also the key that will open the door to additional major medical advances and breakthroughs in the future.

Our staff at Medifocus is committed to keeping our subscribers to the Medifocus Digest Alert on Bladder Cancer abreast of the latest new research developments that have recently been published in the medical literature for this condition. In this issue of the Digest Alert, you will find a focused list of hand-picked journal article references that represent the latest advances in basic and clinical research for Bladder Cancer. These articles represent the current state-of-the-art of the research that will hopefully lead to additional major advances and breakthroughs in the clinical management of Bladder Cancer. You can access the summaries of each article referenced below by simply clicking on the article Title.

We will continue to update you with the latest scientific and clinical developments through the Medifocus Digest Alert on Bladder Cancer every 3 months. Thank you for your ongoing subscription to this publication.

Sincerely,
Elliot Jacob, Ph.D.
Vice-President - Content
Medifocus.com, Inc.



1:Kidney, Ureteral, and Bladder Cancer: A Primer for the Internist.
Authors:Arora HC, Fascelli M, Zhang JH, Isharwal S, Campbell SC
Institution:Center for Urologic Oncology, Glickman Urological and Kidney Institute, Cleveland Clinic, 9500 Euclid Avenue, Q10-1, Cleveland, OH 44195, USA. Electronic address: campbes3@ccf.org.
Journal:Med Clin North Am. 2018 Mar;102(2):231-249. doi: 10.1016/j.mcna.2017.10.002.

2:Male Neobladder.
Authors:Pietzak EJ, Donahue TF, Bochner BH
Institution:Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. New York, NY, USA. New York, NY, USA. Electronic address: bochnerb@mskcc.org.
Journal:Urol Clin North Am. 2018 Feb;45(1):37-48. doi: 10.1016/j.ucl.2017.09.003.

3:Diabetes mellitus and the risk of bladder cancer: A PRISMA-compliant meta-analysis of cohort studies.
Authors:Xu Y, Huo R, Chen X, Yu X
Institution:Department of Endocrinology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Journal:Medicine (Baltimore). 2017 Nov;96(46):e8588. doi: 10.1097/MD.0000000000008588.

4:Bladder Cancer: Diagnosis and Treatment.
Authors:DeGeorge KC, Holt HR, Hodges SC
Institution:University of Virginia School of Medicine, Charlottesville, VA, USA.
Journal:Am Fam Physician. 2017 Oct 15;96(8):507-514.

5:The efficacy of Apaziquone in the treatment of bladder cancer.
Authors:Carames Masana F, de Reijke TM
Institution:a Department of Urology , Complexo Hospitalario Universitario de A Coruna , A Coruna , Spain.
Journal:Expert Opin Pharmacother. 2017 Nov;18(16):1781-1788. doi: 10.1080/14656566.2017.1392510. Epub 2017 Oct 20.

6:Atezolizumab in invasive and metastatic urothelial carcinoma.
Authors:Crist M, Balar A
Institution:a Laura & Isaac Perlmutter Cancer Center , NYU Langone Medical Center , New York , NY , USA. Cancer Center , NYU Langone Medical Center , New York , NY , USA.
Journal:Expert Rev Clin Pharmacol. 2017 Dec;10(12):1295-1301. doi: 10.1080/17512433.2017.1389275. Epub 2017 Oct 30.

7:Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer.
Authors:Giridhar KV, Kohli M
Institution:Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, MN. Electronic address: kohli.manish@mayo.edu.
Journal:Mayo Clin Proc. 2017 Oct;92(10):1564-1582. doi: 10.1016/j.mayocp.2017.07.010.

8:Bladder cancer to patients younger than 30 years: a retrospective study and review of the literature.
Authors:Katafigiotis I, Sfoungaristos S, Martini A, Stravodimos K, Anastasiou I, Mykoniatis I, Duvdevani M, Constantinides C
Institution:1 University Urology Clinic, Laiko Hospital, Athens - Greece. Oncology, Vita-Salute San Raffaele University, IRCCS San Raffaele Scientific Institute, Milan - Italy. Thessaloniki - Greece.
Journal:Urologia. 2017 Oct 25;84(4):231-235. doi: 10.5301/uj.5000264. Epub 2017 Sep 5.

9:The Cancer of the Bladder Risk Assessment (COBRA) score: Estimating mortality after radical cystectomy.
Authors:Welty CJ, Sanford TH, Wright JL, Carroll PR, Cooperberg MR, Meng MV, Porten SP
Institution:Helen Diller Family Comprehensive Cancer Center, Department of Urology, University of California, San Francisco, California.; Department of Urology, University of Washington School of Medicine, Seattle, Washington.
Journal:Cancer. 2017 Dec 1;123(23):4574-4582. doi: 10.1002/cncr.30918. Epub 2017 Sep 7.

10:Bladder-Preserving Therapy Patterns of Care: A Survey of US Radiation Oncologists.
Authors:Solanki AA, Martin B, Korpics M, Small C, Harkenrider MM, Mitin T
Institution:Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois. Electronic address: abhishek.solanki@lumc.edu. Maywood, Illinois. Chicago, Maywood, Illinois. Chicago, Maywood, Illinois. Chicago, Maywood, Illinois. Oregon.
Journal:Int J Radiat Oncol Biol Phys. 2017 Oct 1;99(2):383-387. doi: 10.1016/j.ijrobp.2017.04.009. Epub 2017 Apr 11.

11:Prospects and progress of immunotherapy for bladder cancer.
Authors:Boegemann M, Aydin AM, Bagrodia A, Krabbe LM
Institution:a Department of Urology , University of Muenster Medical Center , Muenster , Germany. Dallas , TX , USA. Turkey. Dallas , TX , USA. Germany. Dallas , TX , USA.
Journal:Expert Opin Biol Ther. 2017 Nov;17(11):1417-1431. doi: 10.1080/14712598.2017.1366445. Epub 2017 Aug 23.

12:Nivolumab for the treatment of bladder cancer.
Authors:Hakenberg OW
Institution:a Department of Urology , Rostock University , Rostock , Germany.
Journal:Expert Opin Biol Ther. 2017 Oct;17(10):1309-1315. doi: 10.1080/14712598.2017.1353076. Epub 2017 Jul 24.

13:Physical activity in the prevention and management of bladder cancer.
Authors:Shephard RJ
Institution:Faculty of Kinesiology and Physical Education, University of Toronto, Toronto, ON, Canada - royjshep@shaw.ca.
Journal:J Sports Med Phys Fitness. 2017 Oct;57(10):1359-1366. doi: 10.23736/S0022-4707.17.06830-X. Epub 2017 Jan 23.

For a FREE PREVIEW of the Medifocus Guidebook on Bladder Cancer click here

To purchase a copy of the COMPLETE Medifocus Guidebook on Bladder Cancer click here

To subscribe to additional FREE Medifocus Digest Alert on other disease/condition areas click here

  
Get the Medifocus Guidebook on Bladder Cancer...
at a Special 20% Discount


Medifocus Guidebook on Bladder Cancer

Updated: January 15, 2018
159 Pages

This one of a kind Guidebook offers:

  • Answers to your critical health questions including the latest treatments, clinical trials, and expert research.
     
  • High Quality, Professional level information you can trust and understand culled from the latest peer-reviewed journals.
     
  • Timely, up to date content with free guidebook updates for 1 year.
     
  • A unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks.
     
  • Over 130,000 Guidebooks Sold
     
  • 100% Risk Free Money Back Guarantee



ORDER THE GUIDEBOOK

The Medifocus Guidebook on Bladder Cancer is available in the following two convenient formats:

PRINTED GUIDEBOOK

Soft-cover book that is available for immediate shipping via either U.S. Priority Mail or International AirMail (outside the U.S.).

  • Regular List Price = $36.95
  • Less 20% Discount = - $7.40
  • Discounted Price = $29.55(excluding shipping & handling)

Order the Printed Guidebook

DIGITAL GUIDEBOOK

Available for immediate download as a PDF document.

  • Regular List Price = $27.95
  • Less 20% Discount = - $5.60
  • Discounted Price = $22.35

Order the Digital Guidebook



Order by Phone

Call Toll Free in the U.S.
1-800-965-3002

From Outside the U.S.
1-301-649-9300

You can also receive a 20% discount when you order your Guidebook by phone.

To receive your 20% discount, simply mention the Discount Coupon Code below to the customer service representative taking your order.

Discount Coupon Code for
Phone Orders

BC22855879

Coupon Expires: March 19, 2018



What Our Customers Are Saying...

"My father, a veterinarian, was recently diagnosed with invasive bladder cancer. In wondering how best to support him, I decided to gift him a copy of the MediFocus Guidebook on Bladder Cancer. I knew it would appeal to his "scientific side". I wrote a loving and personal message in the Guide to remind him how much I loved him and then gave it to him. After reading the Guide, he took it to his Urologist and was able to generate excellent and candid questions about his condition."
R.R.
Modesto, California


"This Medifocus Guidebook was significantly helpful at a time that we needed information quickly. We felt we gained information that offered us insight on what to ask our physician, as well as a preview of options on treatment and risk factors that he would probably discuss with us. Emotionally, it's a 'god-send' to look up and receive information immediately. Thanks."
L.H.S.
Crestview, Florida



  
Medifocus Digest Alert is published monthly by Medifocus, Inc.
6810 Park Heights Avenue, Suite C5, Baltimore, MD 21215 USA
Copyright © 2013 Medifocus, Inc. All rights reserved.